We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Herbalife
HLF
$1.23B
| $7.64M | 0.11% |
178,760
-13,450
| -7% | -$637K |
|
|
AGS
252
DELISTED
PlayAGS
AGS
| $7.64M | 0.11% |
392,807
+261,343
| +199% | +$5.62M |
|
253
Unisys
UIS
$227M
| $7.55M | 0.1% |
777,268
+61,250
| +9% | +$632K |
|
254
DuPont de Nemours
DD
$18.6B
| $7.47M | 0.1% |
+79,252
| New | +$9.46M |
|
|
NXGN
255
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $7.42M | 0.1% |
373,081
-119,928
| -24% | -$2.24M |
|
|
WCC
256
WESCO International
WCC
$16.2B
| $7.41M | 0.1% |
146,288
-28,263
| -16% | -$1.48M |
|
257
Cimpress
CMPR
$2.37B
| $7.39M | 0.1% |
81,276
-229
| -0.3% | -$20.6K |
|
258
Murphy USA
MUSA
$11.3B
| $7.34M | 0.1% |
87,380
+4,890
| +6% | +$409K |
|
259
Tenet Healthcare
THC
$20.1B
| $7.32M | 0.1% |
354,514
+40,650
| +13% | +$937K |
|
260
Herc Holdings
HRI
$5.43B
| $7.29M | 0.1% |
159,182
+83,826
| +111% | +$3.49M |
|
|
WWE
261
DELISTED
World Wrestling Entertainment
WWE
| $7.29M | 0.1% |
100,885
-19,590
| -16% | -$1.6M |
|
|
SIVB
262
DELISTED
SVB Financial Group
SIVB
| $7.26M | 0.1% |
+32,317
| New | +$7.47M |
|
263
Ionis Pharmaceuticals
IONS
$9.35B
| $7.2M | 0.1% |
112,070
+59,380
| +113% | +$4.2M |
|
|
TBI
264
Trueblue
TBI
$234M
| $7.15M | 0.1% |
324,249
+30,140
| +10% | +$699K |
|
265
Boise Cascade
BCC
$2.74B
| $7.15M | 0.1% |
254,249
+36,560
| +17% | +$949K |
|
266
Upbound Group
UPBD
$1.19B
| $7.11M | 0.1% |
267,034
+9,668
| +4% | +$230K |
|
267
Genesco
GCO
$396M
| $7.02M | 0.1% |
166,066
+27,380
| +20% | +$1.21M |
|
268
News Corp Class A
NWSA
$14.5B
| $6.99M | 0.1% |
518,285
-25,700
| -5% | -$314K |
|
269
Rollins
ROL
$18.6B
| $6.98M | 0.1% |
291,833
-184,117
| -39% | -$4.75M |
|
270
Banner Corp
BANR
$2.39B
| $6.87M | 0.1% |
126,902
-3,177
| -2% | -$170K |
|
271
NXP Semiconductors
NXPI
$68B
| $6.87M | 0.1% |
70,330
-67,140
| -49% | -$6.51M |
|
272
Chevron
CVX
$388B
| $6.78M | 0.09% |
54,494
-132,494
| -71% | -$16M |
|
273
Burlington
BURL
$22B
| $6.74M | 0.09% |
39,617
-5,340
| -12% | -$873K |
|
274
Manitowoc
MTW
$516M
| $6.73M | 0.09% |
378,066
+50,360
| +15% | +$836K |
|
275
Northwest Natural Holdings
NWN
$2.17B
| $6.72M | 0.09% |
96,764
+8,130
| +9% | +$550K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.